It's questionable whether Analysts' ratings are worth anything....

It's questionable whether Analysts' ratings are worth anything. Maybe we should be prepared to pay them not to publish. I see that they have upgraded Beach to Neutral from Underperform, with a target price of $1.20. Well, Beach has gone up about 150% in just 9 months, presumably while rated underperform. They are up from $1.20 to $1.59 just since the beginning of April while their target price was $1.05, and the Analysts now think that a target of $1.20 - 25% below today's price - is "Neutral"????? I've lost 25% more often than I would like, but I certainly never feel neutral about it. The story for Healthscope is similar - up 25% since start April from $1.92 to $2.43 while rated Underperform with a target of $1.67.

Hey, let's ignore the ratings and just watch SXY's business grow.